Vagus Nerve Stimulation Clinical Trial
Official title:
Transcutaneous Auricular Vagus Nerve Stimulation: Comparison of Effectiveness of In-ear and Behınd-ear Stimulation
The use of vagus nerve stimulation (VSS), one of the examples of neuromodulation therapies, continues to increase in the medical field. Basically, invasive (iVSS) and transcutaneous VSS (tVSS) can be performed. tVSS is more preferred because of its advantages such as easy application, not requiring surgical procedure and having fewer side effects. VSS has long been an approved treatment modality in the treatment of epilepsy and refractory depression. tVSS can be administered from the auricular-auricular or posterior ear region. The vagus nerve (VS) belongs to the parasympathetic branch of the autonomic nervous system and has an effect on vital functions. There are also studies in the literature showing that VS stimulation reduces inflammation. In addition to this effect, the vagus nerve may also show analgesic activity through pain-related pathways. Due to its anti-inflammatory and analgesic effects, VSS has become a new treatment method in diseases in which various inflammatory processes are shown in the etiology such as inflammatory bowel diseases, musculoskeletal system diseases and central nervous system diseases.
There are no generally accepted values for taVNS (transcutaneous auricular vagus nerve stimulation) application parameters (amplitude, frequency, intensity, duration, side); therefore, there are heterogeneous applications in studies. In a meta-analysis on the safety profile of taVSS, local skin irritation (18. 2%), headache (3.6%), nasopharyngitis (1.7%), dizziness (1.4%) and nausea (1.1%) were reported and taVSS treatment was reported as an effective and safe treatment with these side effects, most of which were transient and did not require additional intervention. During taVNS, autonomic activities increase in favour of the parasympathetic system and this results in an increase in heart rate variability (HRV). Although an increase in HRV has been demonstrated by different studies, the factors that can predict the change in HRV are not clear. In a study by Geng et al. using taVSS, it was observed that HRV indicators representing vagal nerve activity increased significantly when stimulation was performed in the morning, but evening stimulation did not yield similar results. In addition, they found that improvements in measures of autonomic balance were more pronounced in the presence of lower vagal activity; they also found that by increasing the duration of stimulation, the effect of taVNS on HRV was not regulated by duration. In other words, HRV changes had the best effect only at the beginning of stimulation. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05343039 -
Technology Enhanced Adolescent Mental Health (TEAM)
|
N/A | |
Recruiting |
NCT05992259 -
Auricular Vagus Stimulation and STEMI
|
N/A | |
Completed |
NCT04643808 -
taVNS Paired With Bottle Feeding in Infants Failing Oral Feeds
|
Early Phase 1 | |
Not yet recruiting |
NCT05417711 -
Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus
|
N/A | |
Not yet recruiting |
NCT06121947 -
Safety and Efficacy Study of Implantable Neuromodulation for Poststroke Hemiplegia
|
N/A | |
Completed |
NCT04150627 -
Effect of Breathing Maneuvers on Peripheral Glucose Metabolism
|
N/A | |
Recruiting |
NCT06421090 -
Transauricular Vagal Nerve Stimulation Improves Postoperative Delirium in Elderly Patients
|
N/A | |
Recruiting |
NCT06421077 -
Transauricular Vagus Nerve Stimulation Improves Postoperative Delirium in Elderly Patients
|
N/A | |
Not yet recruiting |
NCT06381089 -
Effect Of Robotic Rehabilitation And Vagus Nerve Stimulation In Ischemia Stroke Patients
|
N/A | |
Not yet recruiting |
NCT06421051 -
Transauricular Vagus Nerve Stimulation Improves Postoperative Sleep Disorders in Elderly Patients.
|
N/A | |
Terminated |
NCT04256837 -
Effect of Transcutaneous Electrical Auricular Stimulation of the Vagus Nerve in Kidney Transplant Recipients
|
N/A | |
Completed |
NCT05218109 -
Stress and Sleep Study
|
N/A | |
Recruiting |
NCT05680337 -
Auricular Vagus Stimulation and Heart Rate Variability
|
N/A | |
Completed |
NCT05088135 -
The Effect of Auricular Vagus Nerve Stimulation on EEG and EMG Measurement in Healthy Persons
|
N/A | |
Not yet recruiting |
NCT05866471 -
Pairing Psilocybin With Transcutaneous Auricular Vagus Nerve Stimulation
|
Phase 1 | |
Active, not recruiting |
NCT04632069 -
NAC +taVNS in IDM Who Are Poor Oral Feeders
|
Early Phase 1 | |
Active, not recruiting |
NCT05230628 -
Auricular Vagus Stimulation in Obesity
|
N/A | |
Completed |
NCT06086236 -
Vagus Nerve Stimulation Effects on Autonomic Nervous System Activity
|
N/A | |
Completed |
NCT04341649 -
Multi-device Testing for Autonomic Nervous System Stimulation
|
N/A |